Geisinger Partners With Indivumed for Personalized Medicine Initiative MarketWatch (press release) Indivumed follows highly standardized processes that enable the company to limit cold ischemia time - the time between removal of tissue from the body and the time it is preserved - to less than 10 minutes, guaranteeing tissue samples maintain their ... |
